• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于Raf/MEK/ERK激酶级联反应的闪烁邻近分析:高通量筛选及选择性酶抑制剂的鉴定

A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors.

作者信息

McDonald O B, Chen W J, Ellis B, Hoffman C, Overton L, Rink M, Smith A, Marshall C J, Wood E R

机构信息

Division of Biochemistry, GlaxoWellcome Inc., Research Triangle Park, North Carolina, 27709-13398, USA.

出版信息

Anal Biochem. 1999 Mar 15;268(2):318-29. doi: 10.1006/abio.1998.3030.

DOI:10.1006/abio.1998.3030
PMID:10075822
Abstract

We have developed a quantitative scintillation proximity assay (SPA) that reproduces the Raf/MEK/ERK signal transduction pathway. The components of this assay include human cRaf1, MEK1, and ERK2 and a biotinylated peptide substrate for ERK2. cRaf1 was expressed as a his-tagged protein in insect cells in an active form. MEK1 and ERK2 were expressed in Escherichia coli as glutathione S-transferase (GST)-fusion proteins in their inactive forms. ERK2 was removed from the GST portion of the fusion protein by cleavage with thrombin protease. When the purified components are incubated together, cRaf-1 phosphorylates and activates MEK1, MEK1 phosphorylates and activates ERK2, and ERK2 phosphorylates the peptide, biotin-AAATGPLSPGPFA. Phosphorylation of the peptide using [gamma-33P]ATP is detected following binding to streptavidin-coated SPA beads. The assay detects inhibitors of cRaf1, MEK1, or ERK2, and has been used to screen large numbers of compounds. The specific target of inhibition was subsequently identified with secondary assays described herein.

摘要

我们开发了一种定量闪烁邻近分析(SPA)方法,该方法可重现Raf/MEK/ERK信号转导途径。此分析方法的组成部分包括人源cRaf1、MEK1和ERK2以及ERK2的生物素化肽底物。cRaf1在昆虫细胞中以带组氨酸标签的活性形式表达。MEK1和ERK2在大肠杆菌中以谷胱甘肽S-转移酶(GST)融合蛋白的非活性形式表达。通过凝血酶蛋白酶切割,将ERK2从融合蛋白的GST部分去除。当将纯化的组分一起孵育时,cRaf-1磷酸化并激活MEK1,MEK1磷酸化并激活ERK2,ERK2磷酸化肽生物素-AAATGPLSPGPFA。使用[γ-33P]ATP对肽进行磷酸化后,通过与链霉亲和素包被的SPA微球结合来检测。该分析方法可检测cRaf1、MEK1或ERK2的抑制剂,并已用于筛选大量化合物。随后通过本文所述的二级分析确定抑制的具体靶点。

相似文献

1
A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors.用于Raf/MEK/ERK激酶级联反应的闪烁邻近分析:高通量筛选及选择性酶抑制剂的鉴定
Anal Biochem. 1999 Mar 15;268(2):318-29. doi: 10.1006/abio.1998.3030.
2
Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in madin-darby canine kidney-C7 cells.有丝分裂原活化蛋白激酶激酶MEK1的组成型活性突变体诱导Madin-Darby犬肾C7细胞发生上皮去分化和生长抑制。
J Biol Chem. 1997 Apr 25;272(17):11426-33. doi: 10.1074/jbc.272.17.11426.
3
MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes.在气管肌细胞中,血小板衍生生长因子(PDGF)诱导的细胞外信号调节激酶(ERK)激活和DNA合成需要MEK1。
Am J Physiol. 1997 Mar;272(3 Pt 1):L558-65. doi: 10.1152/ajplung.1997.272.3.L558.
4
Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro.体外Raf-1-MEK-ERK信号转导通路的重建。
Mol Cell Biol. 1993 Nov;13(11):6615-20. doi: 10.1128/mcb.13.11.6615-6620.1993.
5
MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase.丝裂原活化蛋白激酶激酶1(MEKK1)使丝裂原活化蛋白激酶激酶1(MEK1)和丝裂原活化蛋白激酶激酶2(MEK2)磷酸化,但不会导致丝裂原活化蛋白激酶(MAPK)的激活。
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6808-12. doi: 10.1073/pnas.92.15.6808.
6
MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.MEK1和细胞外信号调节激酶是T细胞中IL-2基因转录刺激所必需的。
J Immunol. 1996 Feb 1;156(3):1020-9.
7
Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.丝裂原活化蛋白激酶(MAPK)激酶、MAPK磷酸酶及Elk-1转录因子上的对接位点竞争结合MAPK,且对酶活性至关重要。
Biochem J. 2003 Mar 15;370(Pt 3):1077-85. doi: 10.1042/BJ20021806.
8
The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo.MEK1的N端ERK结合位点是ERK2在体外进行有效反馈磷酸化以及在体内激活ERK所必需的。
J Biol Chem. 1999 Nov 26;274(48):34029-35. doi: 10.1074/jbc.274.48.34029.
9
Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.Rho家族蛋白对细胞外调节蛋白激酶(ERKs)和三元复合因子的交叉级联激活。
EMBO J. 1997 Nov 3;16(21):6426-38. doi: 10.1093/emboj/16.21.6426.
10
An enzyme-linked immunosorbent assay for the Raf/MEK1/MAPK signaling cascade.一种用于检测Raf/MEK1/丝裂原活化蛋白激酶信号级联反应的酶联免疫吸附测定法。
Anal Biochem. 2001 Jul 1;294(1):48-54. doi: 10.1006/abio.2001.5151.

引用本文的文献

1
The advantages and challenges of sorafenib combination therapy: Drug resistance, toxicity and future directions (Review).索拉非尼联合治疗的优势与挑战:耐药性、毒性及未来方向(综述)
Oncol Lett. 2025 Sep 16;30(5):526. doi: 10.3892/ol.2025.15272. eCollection 2025 Nov.
2
Comparative expression of soluble, active human kinases in specialized bacterial strains.在专门的细菌菌株中比较可溶性、活性人激酶的表达。
PLoS One. 2022 Apr 19;17(4):e0267226. doi: 10.1371/journal.pone.0267226. eCollection 2022.
3
Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis.
米替罗宁通过Gasdermin E(GSDME)依赖的细胞焦亡诱导肝癌细胞死亡。
Acta Pharm Sin B. 2020 Aug;10(8):1397-1413. doi: 10.1016/j.apsb.2020.06.015. Epub 2020 Jul 2.
4
Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide.重组肽生产平台与位点特异性白蛋白缀合相结合,可实现长效治疗性肽的便捷生产。
Pharmaceutics. 2020 Apr 16;12(4):364. doi: 10.3390/pharmaceutics12040364.
5
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.通过一种新型双抑制剂靶向前列腺癌细胞中的Btk/Etk。
Cell Death Dis. 2014 Sep 4;5(9):e1409. doi: 10.1038/cddis.2014.343.
6
Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays.在临床前试验中发现具有抗肿瘤活性的强效口服活性酪氨酸激酶和丝氨酸/苏氨酸蛋白激酶抑制剂化合物。
Afr J Tradit Complement Altern Med. 2012 Apr 2;9(3):431-9. doi: 10.4314/ajtcam.v9i3.20. eCollection 2012.
7
CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.CTA095,一种新型的 Etk 和Src 双重抑制剂,可诱导前列腺癌细胞凋亡,并克服对Src 抑制剂的耐药性。
PLoS One. 2013 Aug 15;8(8):e70910. doi: 10.1371/journal.pone.0070910. eCollection 2013.
8
Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update.索拉非尼在治疗晚期肝细胞癌中的作用:最新进展。
Hepatol Res. 2013 Feb;43(2):147-54. doi: 10.1111/j.1872-034X.2012.01113.x. Epub 2012 Nov 12.
9
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.CTA056 是一种新型的白细胞介素-2 诱导的 T 细胞激酶抑制剂,其分子特征为选择性靶向恶性 T 细胞并调节致癌 miRNA。
Mol Pharmacol. 2012 Nov;82(5):938-47. doi: 10.1124/mol.112.079889. Epub 2012 Aug 16.
10
Phosphatase-coupled universal kinase assay and kinetics for first-order-rate coupling reaction.磷酸酶偶联通用激酶测定法及其在一级速率偶联反应中的动力学。
PLoS One. 2011;6(8):e23172. doi: 10.1371/journal.pone.0023172. Epub 2011 Aug 11.